Literature DB >> 10943929

Fracture mechanics model of stone comminution in ESWL and implications for tissue damage.

M Lokhandwalla1, B Sturtevant.   

Abstract

Focused shock waves administered during extracorporeal shock-wave lithotripsy (ESWL) cause stone fragmentation. The process of stone fragmentation is described in terms of a dynamic fracture process. As is characteristic of all brittle materials, fragmentation requires nucleation, growth and coalescence of flaws, caused by a tensile or shear stress. The mechanisms, operative in the stone, inducing these stresses have been identified as spall and compression-induced tensile microcracks, nucleating at pre-existing flaws. These mechanisms are driven by the lithotripter-generated shock wave and possibly also by cavitation effects in the surrounding fluid. In this paper, the spall mechanism has been analysed, using a cohesive-zone model for the material. The influence of shock wave parameters, and physical properties of stone, on stone comminution is described. The analysis suggests a potential means to exploit the difference between the stone and tissue physical properties, so as to make stone comminution more effective, without increasing tissue damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943929     DOI: 10.1088/0031-9155/45/7/316

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  20 in total

1.  Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis.

Authors:  Ahmet Tezel; Samir Mitragotri
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

2.  Effect of lithotripter focal width on stone comminution in shock wave lithotripsy.

Authors:  Jun Qin; W Neal Simmons; Georgy Sankin; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2010-04       Impact factor: 1.840

3.  [Extracorporeal shockwave lithotripsy. Past, present and future].

Authors:  C Chaussy; T Bergsdorf; S Thüroff
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

4.  Progressive increase of lithotripter output produces better in-vivo stone comminution.

Authors:  Michaella E Maloney; Charles G Marguet; Yufeng Zhou; David E Kang; Jeffery C Sung; W Patrick Springhart; John Madden; Pei Zhong; Glenn M Preminger
Journal:  J Endourol       Date:  2006-09       Impact factor: 2.942

Review 5.  The acute and long-term adverse effects of shock wave lithotripsy.

Authors:  James A McAteer; Andrew P Evan
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

6.  Interaction of lithotripter shockwaves with single inertial cavitation bubbles.

Authors:  Evert Klaseboer; Siew Wan Fong; Cary K Turangan; Boo Cheong Khoo; Andrew J Szeri; Michael L Calvisi; Georgy N Sankin; Pei Zhong
Journal:  J Fluid Mech       Date:  2007       Impact factor: 3.627

7.  A heuristic model of stone comminution in shock wave lithotripsy.

Authors:  Nathan B Smith; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

8.  Enhanced High-Rate Shockwave Lithotripsy Stone Comminution in an In Vivo Porcine Model Using Acoustic Bubble Coalescence.

Authors:  Hedieh Alavi Tamaddoni; William W Roberts; Alexander P Duryea; Charles A Cain; Timothy L Hall
Journal:  J Endourol       Date:  2016-12       Impact factor: 2.942

9.  Improving the lens design and performance of a contemporary electromagnetic shock wave lithotripter.

Authors:  Andreas Neisius; Nathan B Smith; Georgy Sankin; Nicholas John Kuntz; John Francis Madden; Daniel E Fovargue; Sorin Mitran; Michael Eric Lipkin; Walter Neal Simmons; Glenn M Preminger; Pei Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

Review 10.  Targeted microbubbles: a novel application for the treatment of kidney stones.

Authors:  Krishna Ramaswamy; Vanessa Marx; Daniel Laser; Thomas Kenny; Thomas Chi; Michael Bailey; Mathew D Sorensen; Robert H Grubbs; Marshall L Stoller
Journal:  BJU Int       Date:  2015-03-17       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.